PICO Questions and DELPHI Methodology for the Management of Venous Thromboembolism Associated with COVID-19
Patients with coronavirus disease 2019 (COVID-19) have a higher risk of venous thromboembolic disease (VTE) than patients with other infectious or inflammatory diseases, both as macrothrombosis (pulmonar embolism and deep vein thrombosis) or microthrombosis. However, the use of anticoagulation in th...
Saved in:
Main Authors: | Antoni Riera-Mestre, Luis Jara-Palomares, Ramón Lecumberri, Javier Trujillo-Santos, Enric Grau, Angeles Blanco-Molina, Ana Piera Carbonell, Sonia Jiménez, Manuel Frías Vargas, Mari Paz Fuset, Sergi Bellmunt-Montoya, Manuel Monreal, David Jiménez, on behalf of the COVILAX Project |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/248f349217204683a5cbf63ef1fce525 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Avances en la prevención de eventos tromboembólicos en pacientes con fibrilación auricular
by: Montagna M,Rodrigo, et al.
Published: (2007) -
Rivaroxaban in acute venous thromboembolism: UK prescribing experience
by: Victoria Speed, et al.
Published: (2021) -
Profilaxis de enfermedad tromboembólica en pacientes hospitalizados con patología médica, estrechando la brecha entre las guías y la práctica clínica
by: Aizman,Andrés, et al.
Published: (2011) -
Mean platelet volume as a prognostic factor for venous thromboembolic disease
by: Díaz,Juan Manuel, et al.
Published: (2019) -
Anticoagulation in Patients with Liver Cirrhosis (Literature Review)
by: E. S. Eniseeva
Published: (2019)